Innovation America Innovation America Accelerating the growth of the GLOBAL entrepreneurial innovation economy
Founded by Rich Bendis

innovation DAILY

Here we highlight selected innovation related articles from around the world on a daily basis.  These articles related to innovation and funding for innovative companies, and best practices for innovation based economic development.


Biopharma venture capital activity maintained its red-hot pace during the third quarter of 2018, driven by a handful of deals exceeding $200 million, according to a report released this week.

Investors raised $4.002 billion in 130 biopharma VC deals during Q3 2018, according to the most recent quarterly PwC/CB Insights MoneyTree™ Report. That’s 51% above the $2.643 billion in 122 deals recorded for July–September 2017.

Those figures do not include “stealth mode” investments also recorded in the “healthcare” sector, for which details are unavailable. The value of those deals declined year over year, to $14.01 million in Q3 2018 from $49.08 million a year earlier, though the number of stealth deals remained consistent at four.


Read more ...


Europe’s biotech industry recently celebrated its growth and progress with more than 120 events taking place across 18 European countries September 24 –30, in what organizers call “European Biotech Week.”

But during a roundtable discussion held in Brussels, the planned discussion topic, biotech’s contribution toward the United Nations’ third Sustainable Development Goal, “Ensure healthy lives and promote well-being for all at all ages,” was overshadowed, according to European news website Euractiv, by worries expressed by stakeholders that the continent’s biopharma industry is less attractive to investors than the world’s largest biopharma industry in the United States, and the fast-growing biopharma industry that has taken shape in China.


Read more ...


The number of open innovation challenges in pharma grows by the day. But what’s driving them? That’s what Luminary Labs wanted to know. So the consultancy, which works with pharma and other industries to design and execute those kind of challenges, surveyed the executives at companies that run the contests and asked why and how they do it.

Image: Looking for innovation, pharma and other industries are turning to crowdsourced challenges as a way to bring in outside solutions, partners and thinking. (Pixabay)

Read more ...


To help the former mobile giant find a radically new strategic direction, Nokia’s board assumed a unique role.

Nokia’s mobile-phone downfall – from a 40 percent market share to near bankruptcy in just a few years – has become a familiar cautionary parable on the perils of industry disruption. Less well-known is the equally instructive tale of how Nokia clawed its way back from the edge of destruction. Indeed, since touching bottom in 2012, its market capitalisation, while not at the level of its pre-smartphone heyday, has increased more than five-fold.


Read more ...


U.S. healthcare companies have collected $23.4 billion in venture capital funding this year — already surpassing the amount the sector obtained in all of 2017, according to a recent report from Pitchbook, which tracks VC investments.

For the healthcare sector, pharmaceuticals and biotechnology amassed the most cash, raking in more than $14 billion in 548 deals through the third quarter of 2018. This is more than they've collected in any previous year. Healthcare services and systems raised about $4.3 billion in 376 deals, and healthcare devices and supplies raised about $4.6 billion in 433 deals.


Read more ...


INDIANAPOLIS, Oct. 10, 2018 /PRNewswire/ -- BioCrossroads today announced the formation of its $9 million Indiana Seed Fund III at its Indiana Life Sciences Summit. 

The Indiana Seed Fund III is an early-stage fund focused on identifying, creating and developing the next generation of leading Indiana-based life sciences, health IT, and agbiosciences companies and follow-on fund to the $8.25 million Indiana Seed Fund II. 

BioCrossroads has raised nearly $25 million in seed funding since 2005, resulting in investments in 24 start-up companies. Those companies have gone on to raise more than $400 million, including companies like:


Read more ...

Bioforward 2018 Economic Impact Report pdf

MADISON, Wis.--(BUSINESS WIRE)--Today BioForward Wisconsin, the member-driven association that serves as the voice of Wisconsin’s biohealth industry, unveiled a new third-party report highlighting the statewide economic impact of Wisconsin’s biohealth industry. Featuring strong job growth, multiplier effect, building expansion impact, and manufacturing supply chain data, the Wisconsin Biohealth Industry 2018 Economic Impact Report showcases the thriving industry including:


Read more ...

Andrew Karam

There’s a good chance you haven’t heard of Farmers Business Network (FBN). It sounds like a generic professional organization for the agriculture industry, which it’s not, but what it’s really doing isn’t exactly mind-blowing, either: FBN is a social network that lets farmers pool and compare data and that offers seeds to its users at discounted rates.


Read more ...

career problem

A rut is never a fun place to be in, but it happens to nearly all of us at some point in our careers. Perhaps you’ve been working in a job for a while, doing the same tasks, working with the same people in the same office every day. Suddenly you wake up one morning and realize you’re no longer inspired by your job. You wonder if it’s time to move on, or if you should stick with it and hope things get better.


Read more ...


Organizations need to invest in the cultivation of capacity for innovation and recognize innovators with varying talent and strengths.

Innovation is about the future, without it, you lose sight of tomorrow. Innovation is an exceptional, exclusive, and realistic idea that separates you from others without a second thought. Innovation can happen anywhere in the organization and its ecosystem.


Read more ...